全球硬脑膜移植市场

预计到 2030 年全球硬脑膜移植市场规模将达 11 亿美元

全球硬脑膜移植市场规模预计在2024年为8.135亿美元，预计到2030年将达到11亿美元，在2024-2030年的分析期内，复合年增长率为4.5%。异种移植硬脑膜是本报告分析的细分市场之一，预计其复合年增长率为4.4%，到分析期结束时市场规模将达到3.419亿美元。同种异体硬脑膜移植市场在分析期间的复合年增长率预计为5.1%。

美国市场规模将达 2.216 亿美元；中国市场预期复合年增长率为 8.1%

预计2024年美国硬脑膜移植市场规模将达2.216亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到2.181亿美元，在2024-2030年的分析期内，复合年增长率为8.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.9%和3.5%。在欧洲，预计德国市场的复合年增长率为2.6%。

全球硬脑膜移植市场—主要趋势与驱动因素摘要

医学界引进硬脑膜移植的动力是什么？

硬脑膜移植已成为神经外科和脊椎外科的基石，特别是在涉及硬脑膜断裂、颅骨减压手术和脊椎硬脑膜成形术的病例中。这些移植物是硬脑膜（包覆大脑和脊髓的保护膜）的重要补片或替代品。创伤性脑损伤、脊髓损伤和神经外科手术的发生率不断上升，对可靠的硬脑膜修復材料的需求也越来越大。随着人们对脑脊髓液 (CSF) 漏等术后併发症的认识不断提高，有效闭合硬脑膜的重要性从未被强调。外科医生现在优先考虑不仅能作为功能屏障，而且还能与原生组织良好结合的移植物，促进癒合并降低感染和粘连的风险。旨在改善手术结果和减少併发症的医疗保健系统的转变在加速全球采用先进的硬脑膜移植材料方面发挥关键作用。

材料创新如何改变植入物的功能？

硬脑膜移植市场最重要的发展之一是生物材料的演变。最初，从患者自身体内采集的自体移植被认为是黄金标准，但其局限性（例如供体部位发病率和手术时间延长）促使合成和异质骨移植替代品的开发。现今的硬脑膜移植包括基于胶原蛋白的异质骨移植（通常来自牛或猪）、聚氨酯和发泡聚四氟乙烯 (ePTFE) 等合成聚合物以及混合生物工程材料。这些材料具有优异的生物相容性、抗拉强度和防水密封能力，并且通常具有其他优势，例如抗炎涂层和可控的降解时间。有些材料还具有支架结构，可促进自体细胞生长和组织再生。此外，无缝线和密封剂相容的移植材料显着提高了手术的便利性和速度。这些技术改进不仅使手术更加高效，而且还降低了脑脊髓液洩漏和感染的风险，而这些都是临床决策的关键因素。

为什么地方医​​疗系统会加速使用贪污贿赂？

受医疗基础设施、监管核准流程和手术量的影响，不同地区的硬脑膜移植应用呈现不同的趋势。北美和欧洲凭藉其强大的神经外科网路、较高的手术量和优惠的报销制度，在应用方面处于领先地位。这些地区也更容易获得优质的移植材料，临床医生偏好有实证依据的产品。同时，亚太地区的需求正在激增，这得益于医疗覆盖面的扩大、对手术品质的认识的提高以及创伤相关神经外科病例的增加。此外，印度和中国等国家的三级医院和专科医院的手术能力正在快速提升，这推动了先进硬脑膜修復产品的普及。在拉丁美洲以及中东和非洲部分地区，市场成长尚处于相对起步阶段，但随着全球医疗科技公司扩大业务范围并推出针对新兴市场的经济高效的移植解决方案，市场成长势头正在增强。这种市场多元化正在拓展整体市场潜力，并鼓励更广泛地接受硬脑膜移植技术。

推动硬脑膜移植市场成长轨迹的因素是什么？

硬脑膜移植市场的成长受多种因素驱动。其中最主要的是全球神经外科和脊椎外科手术数量的不断增长，这些手术需要有效的硬脑膜修復解决方案。移植材料设计的创新，例如更高的生物相容性、更低的发炎反应以及对组织再生的支持，正在增强外科医生的信心并改善临床疗效。向微创手术的转变也有利于在更狭窄的手术通道中快速可靠地植入先进的移植材料。此外，对脑脊髓液 (CSF) 相关併发症的认识不断提高，以及具有卓越密封性能的移植材料的供应，正在降低术后发病率，进一步推动其应用。新产品的监管核准以及移植临床适应症的不断扩大，使得这些设备在已开发经济体和新兴经济体的医疗保健系统中更容易获得。对患者復健指标、再入院率和长期疗效的日益关注，也鼓励医疗保健机构投资可靠且成熟的移植技术。这些因素共同推动全球硬脑膜移植市场进入持续加速成长阶段。

部分

产品（国外主题词、同源主题词、合成主题词、自体主题词、其他产品）、材料（牛材料、尸体硬脑膜材料、自体心包材料、合成牛胶原蛋白基质材料、硬脑膜材料、其他材料）、应用（脑外伤及脊髓损伤应用、脑血管疾病应用、脑脊髓液储存应用、脑部及脊髓肿瘤应用、癫痫应用、其他应用）、最终用途（医院最终用途、门诊手术中心最终用途、创伤中心最终用途、诊所最终用途）

受访公司范例（43家值得关注的公司）

• Acera Surgical
• Aesculap, Inc.（B. Braun）
• Baxter International Inc.
• Beijing TianXinFu Medical Appliance
• B. Braun Melsungen AG
• Collagen Matrix, Inc.
• Cook Medical
• Cousin Biotech
• Guanhao Biotech
• Gunze Limited
• Integra LifeSciences Corporation
• Johnson & Johnson（DePuy Synthes）
• LeMaitre Vascular
• Medprine
• Medtronic plc
• Natus Medical Incorporated
• Nurami Medical
• Stryker Corporation
• Tissuemed Ltd
• WL Gore & Associates

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Dural Graft Market to Reach US$1.1 Billion by 2030

The global market for Dural Graft estimated at US$813.5 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Xenogeneic Dural Graft, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$341.9 Million by the end of the analysis period. Growth in the Allogenic Dural Graft segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$221.6 Million While China is Forecast to Grow at 8.1% CAGR

The Dural Graft market in the U.S. is estimated at US$221.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$218.1 Million by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Dural Graft Market - Key Trends & Drivers Summarized

What’s Driving the Medical Community Toward Dural Graft Adoption?

Dural grafts have become a cornerstone in neurosurgical and spinal procedures, especially in cases involving dural tears, cranial decompression, and spinal duraplasty. These grafts serve as critical patches or substitutes for the dura mater-the protective membrane surrounding the brain and spinal cord-especially when the native dura is damaged or removed. The rising incidence of traumatic brain injuries, spinal disorders, and neurosurgical interventions has created a robust demand for reliable dural repair materials. As awareness of postoperative complications such as cerebrospinal fluid (CSF) leaks grows, the importance of effective dural closure has never been more emphasized. Surgeons now prioritize grafts that not only serve a functional barrier but also integrate well with native tissue, promote healing, and reduce the risk of infection or adhesion. The healthcare system’s shift toward improving surgical outcomes and minimizing complications is playing a critical role in accelerating the adoption of advanced dural graft materials across the globe.

How Are Material Innovations Transforming Graft Functionality?

One of the most significant developments in the dural graft market lies in the evolution of biomaterials. Originally, autologous grafts taken from the patient's own body were considered the gold standard, but their limitations-such as donor site morbidity and extended surgery time-spurred the development of synthetic and xenogeneic alternatives. Today’s dural grafts include collagen-based xenografts (typically derived from bovine or porcine sources), synthetic polymers like polyurethane or expanded polytetrafluoroethylene (ePTFE), and hybrid bioengineered materials. These offer excellent biocompatibility, tensile strength, and watertight sealing capabilities, often with added benefits such as anti-inflammatory coatings or controlled degradation timelines. Some are also engineered with scaffold structures that encourage native cell proliferation and tissue regeneration. Furthermore, sutureless grafts and sealant-compatible grafts have significantly improved procedural ease and speed. These technological enhancements not only make surgeries more efficient but also reduce the risk of CSF leaks and infection, key factors in clinical decision-making.

Why Are Regional Healthcare Systems Accelerating Graft Usage?

Different geographic regions exhibit varied dynamics in dural graft adoption, driven by healthcare infrastructure, regulatory approval processes, and surgical volumes. North America and Europe lead in usage, supported by strong neurosurgical networks, high procedural volumes, and favorable reimbursement frameworks. In these regions, there is greater availability of premium graft materials and stronger clinician preference for evidence-backed products. Asia-Pacific, on the other hand, is experiencing a surge in demand driven by expanding healthcare access, growing awareness about surgical quality, and increasing incidences of trauma-related neurosurgical cases. Moreover, countries like India and China are seeing a rapid upscaling in surgical capabilities in tertiary and specialty hospitals, thus encouraging adoption of advanced dural repair products. In Latin America and parts of the Middle East and Africa, market growth is comparatively nascent but gaining momentum as global medtech companies expand their presence and introduce cost-effective graft solutions tailored for emerging markets. This geographic diversification is broadening the overall market potential and ensuring a more widespread acceptance of dural graft technologies.

What Is Fueling the Growth Trajectory of the Dural Graft Market?

The growth in the dural graft market is driven by several factors. Foremost is the rising global volume of neurosurgical and spinal surgeries, necessitating effective dural repair solutions. Innovations in graft material design-such as enhanced biocompatibility, reduced inflammatory response, and support for tissue regeneration-are increasing surgeon confidence and clinical outcomes. The shift toward minimally invasive procedures also favors advanced grafts that can be deployed quickly and reliably through smaller surgical corridors. Additionally, heightened awareness of CSF-related complications and the availability of grafts with superior sealing capabilities are reducing postoperative morbidity, further boosting adoption. Regulatory approvals for new products and expanding clinical indications for graft use are making these devices more accessible in both developed and emerging healthcare systems. The rising emphasis on patient recovery metrics, hospital readmission rates, and long-term outcomes is also pushing institutions to invest in reliable and proven graft technologies. Together, these factors are propelling the global dural graft market into a phase of sustained and accelerated growth.

SCOPE OF STUDY:

The report analyzes the Dural Graft market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft, Other Products); Material (Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material, Synthetic Bovine Collagen Matrix Material, Ligamentum Nuchae Material, Other Materials); Application (Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use, Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Acera Surgical
• Aesculap, Inc. (B. Braun)
• Baxter International Inc.
• Beijing TianXinFu Medical Appliance
• B. Braun Melsungen AG
• Collagen Matrix, Inc.
• Cook Medical
• Cousin Biotech
• Guanhao Biotech
• Gunze Limited
• Integra LifeSciences Corporation
• Johnson & Johnson (DePuy Synthes)
• LeMaitre Vascular
• Medprine
• Medtronic plc
• Natus Medical Incorporated
• Nurami Medical
• Stryker Corporation
• Tissuemed Ltd
• WL Gore & Associates

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Dural Graft - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rise in Neurosurgical Procedures and Spinal Surgeries Drives Demand for Dural Graft Products
  • Growing Geriatric Population Expands Addressable Market for Dural Repair Solutions
  • Technological Advancements in Synthetic Grafts Propel Adoption Over Autografts
  • Increase in Minimally Invasive Neurosurgeries Generates Demand for Advanced Biomaterials
  • Enhanced Biocompatibility and Reduced Infection Rates Strengthen Business Case for Next-Gen Grafts
  • Government Investment in Neurotrauma and Brain Injury Treatments Spurs Market Development
  • Shift Toward Regenerative Medicine and Tissue Engineering Drives Innovation in Dural Grafts
  • Clinical Success and Outcome-Based Reimbursements Accelerate Use of Premium Products
  • Surge in Cranial and Spinal Trauma Cases Globally Generates Continuous Product Demand
  • Growing Focus on Postoperative Outcomes Throws the Spotlight on Durable and Absorbable Grafts
  • Strategic Hospital Procurement Trends Favor Multi-Functional, Long Shelf-Life Graft Options
  • Customization and Surgeon-Specific Preferences Drive Adoption of Tailored Graft Sizes
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Dural Graft Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Xenogeneic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Xenogeneic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Xenogeneic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Allogenic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Allogenic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Allogenic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Synthetic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Synthetic Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Synthetic Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Autologous Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Autologous Dural Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Autologous Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Ligamentum Nuchae Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Ligamentum Nuchae Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Ligamentum Nuchae Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Materials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Bovine Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Bovine Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Bovine Pericardium Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cadaveric Dura Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cadaveric Dura Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Cadaveric Dura Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Autologous Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Autologous Pericardium Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Autologous Pericardium Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Synthetic Bovine Collagen Matrix Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Synthetic Bovine Collagen Matrix Material by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Synthetic Bovine Collagen Matrix Material by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Traumatic Brain & Spine Injury Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Traumatic Brain & Spine Injury Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Traumatic Brain & Spine Injury Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Cerebrovascular Accident Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Cerebrovascular Accident Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Cerebrovascular Accident Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Cerebrospinal Fluid Accumulation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Cerebrospinal Fluid Accumulation Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Cerebrospinal Fluid Accumulation Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Brain & Spine Tumor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Brain & Spine Tumor Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Brain & Spine Tumor Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Epilepsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Epilepsy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 52: World 16-Year Perspective for Epilepsy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 55: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 58: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 61: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Trauma Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Trauma Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 64: World 16-Year Perspective for Trauma Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 67: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 68: USA Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: USA Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 70: USA 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 71: USA Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 73: USA 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 76: USA 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 77: USA Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: USA Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 79: USA 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 80: Canada Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Canada Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 82: Canada 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 83: Canada Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Canada Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 85: Canada 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 88: Canada 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 89: Canada Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Canada Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 91: Canada 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 92: Japan Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Japan Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 94: Japan 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 95: Japan Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Japan Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 97: Japan 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 98: Japan Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Japan Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 100: Japan 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 103: Japan 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 104: China Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: China Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 106: China 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 107: China Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: China Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 109: China 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 110: China Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: China Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 112: China 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 113: China Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: China Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 115: China 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 116: Europe Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 117: Europe Historic Review for Dural Graft by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 118: Europe 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 119: Europe Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Europe Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 121: Europe 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 122: Europe Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Europe Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 124: Europe 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 125: Europe Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Europe Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 127: Europe 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 128: Europe Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Europe Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 130: Europe 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 131: France Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: France Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 133: France 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 134: France Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: France Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 136: France 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 137: France Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: France Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 139: France 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 140: France Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: France Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 142: France 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 143: Germany Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Germany Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 145: Germany 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 146: Germany Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Germany Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 148: Germany 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 149: Germany Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Germany Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 151: Germany 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 152: Germany Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Germany Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 154: Germany 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 155: Italy Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Italy Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 157: Italy 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 158: Italy Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Italy Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 160: Italy 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 161: Italy Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Italy Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 163: Italy 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 164: Italy Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Italy Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 166: Italy 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 167: UK Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: UK Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 169: UK 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 170: UK Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: UK Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 172: UK 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 173: UK Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: UK Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 175: UK 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 176: UK Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: UK Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 178: UK 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 179: Spain Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Spain Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 181: Spain 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 182: Spain Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Spain Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 184: Spain 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 185: Spain Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Spain Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 187: Spain 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 188: Spain Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Spain Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 190: Spain 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 191: Russia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Russia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 193: Russia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 194: Russia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Russia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 196: Russia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 197: Russia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Russia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 199: Russia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 200: Russia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Russia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 202: Russia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 203: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Europe Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Europe 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 206: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Rest of Europe Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 208: Rest of Europe 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 209: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Rest of Europe Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 211: Rest of Europe 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 212: Rest of Europe Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Rest of Europe Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 214: Rest of Europe 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 216: Asia-Pacific Historic Review for Dural Graft by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 217: Asia-Pacific 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 218: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Asia-Pacific Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 220: Asia-Pacific 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 221: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Asia-Pacific Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 223: Asia-Pacific 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 224: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Asia-Pacific Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 226: Asia-Pacific 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 227: Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Asia-Pacific Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 229: Asia-Pacific 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 230: Australia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Australia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 232: Australia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 233: Australia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Australia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 235: Australia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 236: Australia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Australia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 238: Australia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 239: Australia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Australia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 241: Australia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 242: India Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: India Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 244: India 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 245: India Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: India Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 247: India 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 248: India Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: India Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 250: India 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 251: India Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: India Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 253: India 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 254: South Korea Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: South Korea Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 256: South Korea 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 257: South Korea Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: South Korea Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 259: South Korea 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 260: South Korea Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: South Korea Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 262: South Korea 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 263: South Korea Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: South Korea Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 265: South Korea 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 266: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Rest of Asia-Pacific Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 268: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 269: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Rest of Asia-Pacific Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 271: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 272: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Rest of Asia-Pacific Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 274: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 275: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Rest of Asia-Pacific Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 277: Rest of Asia-Pacific 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 278: Latin America Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 279: Latin America Historic Review for Dural Graft by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 280: Latin America 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 281: Latin America Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Latin America Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 283: Latin America 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 284: Latin America Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Latin America Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 286: Latin America 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 287: Latin America Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Latin America Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 289: Latin America 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 290: Latin America Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Latin America Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 292: Latin America 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 293: Argentina Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Argentina Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 295: Argentina 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 296: Argentina Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Argentina Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 298: Argentina 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 299: Argentina Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Argentina Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 301: Argentina 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 302: Argentina Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Argentina Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 304: Argentina 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 305: Brazil Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Brazil Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 307: Brazil 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 308: Brazil Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Brazil Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 310: Brazil 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 311: Brazil Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Brazil Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 313: Brazil 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 314: Brazil Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Brazil Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 316: Brazil 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 317: Mexico Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Mexico Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 319: Mexico 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 320: Mexico Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Mexico Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 322: Mexico 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 323: Mexico Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Mexico Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 325: Mexico 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 326: Mexico Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Mexico Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 328: Mexico 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 329: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Latin America Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 331: Rest of Latin America 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 332: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Rest of Latin America Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 334: Rest of Latin America 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 335: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Rest of Latin America Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 337: Rest of Latin America 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 338: Rest of Latin America Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Rest of Latin America Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 340: Rest of Latin America 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 341: Middle East Recent Past, Current & Future Analysis for Dural Graft by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 342: Middle East Historic Review for Dural Graft by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 343: Middle East 16-Year Perspective for Dural Graft by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 344: Middle East Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Middle East Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 346: Middle East 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 347: Middle East Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Middle East Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 349: Middle East 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 350: Middle East Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Middle East Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 352: Middle East 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 353: Middle East Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Middle East Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 355: Middle East 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 356: Iran Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Iran Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 358: Iran 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 359: Iran Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Iran Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 361: Iran 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 362: Iran Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Iran Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 364: Iran 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 365: Iran Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Iran Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 367: Iran 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 368: Israel Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Israel Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 370: Israel 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 371: Israel Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Israel Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 373: Israel 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 374: Israel Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Israel Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 376: Israel 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 377: Israel Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Israel Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 379: Israel 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 380: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Saudi Arabia Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 382: Saudi Arabia 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 383: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Saudi Arabia Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 385: Saudi Arabia 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 386: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Saudi Arabia Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 388: Saudi Arabia 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 389: Saudi Arabia Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Saudi Arabia Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 391: Saudi Arabia 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 392: UAE Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 393: UAE Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 394: UAE 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 395: UAE Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 396: UAE Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 397: UAE 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 398: UAE Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 399: UAE Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 400: UAE 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 401: UAE Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 402: UAE Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 403: UAE 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 404: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Middle East Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 406: Rest of Middle East 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 407: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Middle East Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 409: Rest of Middle East 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 410: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 411: Rest of Middle East Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 412: Rest of Middle East 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 413: Rest of Middle East Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Rest of Middle East Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 415: Rest of Middle East 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Dural Graft Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 416: Africa Recent Past, Current & Future Analysis for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Africa Historic Review for Dural Graft by Product - Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 418: Africa 16-Year Perspective for Dural Graft by Product - Percentage Breakdown of Value Sales for Xenogeneic Dural Graft, Allogenic Dural Graft, Synthetic Dural Graft, Autologous Dural Graft and Other Products for the Years 2014, 2025 & 2030
  • TABLE 419: Africa Recent Past, Current & Future Analysis for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Africa Historic Review for Dural Graft by Material - Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 421: Africa 16-Year Perspective for Dural Graft by Material - Percentage Breakdown of Value Sales for Ligamentum Nuchae Material, Other Materials, Bovine Pericardium Material, Cadaveric Dura Material, Autologous Pericardium Material and Synthetic Bovine Collagen Matrix Material for the Years 2014, 2025 & 2030
  • TABLE 422: Africa Recent Past, Current & Future Analysis for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Africa Historic Review for Dural Graft by Application - Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 424: Africa 16-Year Perspective for Dural Graft by Application - Percentage Breakdown of Value Sales for Traumatic Brain & Spine Injury Application, Cerebrovascular Accident Application, Cerebrospinal Fluid Accumulation Application, Brain & Spine Tumor Application, Epilepsy Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 425: Africa Recent Past, Current & Future Analysis for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Africa Historic Review for Dural Graft by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 427: Africa 16-Year Perspective for Dural Graft by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use, Trauma Centers End-Use and Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION